Judging from the current situation, if we want to let the new coronavirus epidemic pass quickly, we hope that the new coronavirus vaccine will be developed soon.
According to CCTV, a scientific research team led by Chen Wei of the Military Medical Research Institute of the Academy of Military Sciences successfully developed a new recombinant coronavirus vaccine, and the new recombinant coronavirus vaccine was approved to start clinical trials.
Wu Zunyou, chief expert of epidemiology at the Chinese Center for Disease Control and Prevention, was asked in an interview when the vaccine will be marketed.
In this regard, Wu Zunyou said first of all, congratulations to Chen Wei for making significant progress in vaccine research. Even if it is a special event, the vaccine will go through three clinical trials.
According to the shortest period of time, the clinical period is not less than 20 days.
For the clinical phase II, testing procedures and procedures for clinical vaccination will take about 200 to 300 people, and recruitment will take a minimum of one month.
Phase III clinical trials assess the effectiveness of the vaccine. If the morbidity of the patient is relatively high, a smaller sample size is required, and the shortest time may be three to five months.
In other words, if the Phase III clinical trial is completed and the vaccine is concluded, it will take a minimum of six months, according to CCTV.
Professor Zhang Wenhong, director of the Department of Infectious Diseases, Huashan Hospital affiliated to Fudan University, said that China has reached a dark time, but now Europe has suddenly become a new epidemic center, which has brought us huge uncertainty.
In the future, China still faces large import risks. According to the current global epidemic situation, it is almost impossible for this epidemic to end this summer.
Special Report: Fighting The New Coronavirus
